See more : LAIX Inc. (LAIXY) Income Statement Analysis – Financial Results
Complete financial analysis of Vicarious Surgical Inc. (RBOT) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Vicarious Surgical Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- Heian Ceremony Service Co.,Ltd. (2344.T) Income Statement Analysis – Financial Results
- Forcera Materials Co., Ltd. (3467.TWO) Income Statement Analysis – Financial Results
- Integrated Financial Holdings, Inc. (IFHI) Income Statement Analysis – Financial Results
- Mister International Enterprise Corp. (2941.TWO) Income Statement Analysis – Financial Results
- Barloworld Limited (BAW.JO) Income Statement Analysis – Financial Results
Vicarious Surgical Inc. (RBOT)
About Vicarious Surgical Inc.
Vicarious Surgical Inc. engages in developing and selling single-incision surgical robot that virtually transports surgeons inside the patient to perform minimally invasive surgery. It offers Vicarious System, a single-incision surgical robot for ventral hernia repair. The company was incorporated in 2014 and is headquartered in Waltham, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 1.85M | 1.94M | 316.00K | 0.00 | 0.00 |
Gross Profit | -1.85M | -1.94M | -316.00K | 0.00 | 0.00 |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 47.58M | 43.90M | 22.10M | 9.80M | 7.48M |
General & Administrative | 26.86M | 29.72M | 13.50M | 2.33M | 2.05M |
Selling & Marketing | 6.23M | 6.46M | 2.98M | 861.00K | 250.00K |
SG&A | 33.09M | 36.18M | 16.47M | 3.19M | 2.30M |
Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
Cost & Expenses | 80.67M | 80.08M | 38.57M | 12.99M | 9.78M |
Interest Income | 4.43M | 1.44M | 20.00K | 113.00K | 469.00 |
Interest Expense | 25.00K | 200.00K | 89.00K | 3.00K | 0.00 |
Depreciation & Amortization | 1.85M | 1.94M | 316.00K | 157.00K | 104.00K |
EBITDA | -69.19M | 7.30M | -34.80M | -161.18K | -9.68M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -80.67M | -80.08M | -38.57M | -12.99M | -9.78M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 9.60M | 85.24M | 3.02M | 110.00K | 469.00K |
Income Before Tax | -71.07M | 5.16M | -7.27M | -12.88M | -9.31M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 0.00 | -84.00M | -227.00K | 3.00K | -67.86K |
Net Income | -71.07M | 89.16M | -7.04M | -12.88M | -9.31M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -14.70 | 20.77 | -2.19 | -4.91 | -1.70 |
EPS Diluted | -14.60 | 20.99 | -2.19 | -4.91 | -1.70 |
Weighted Avg Shares Out | 4.83M | 4.29M | 3.22M | 2.62M | 5.47M |
Weighted Avg Shares Out (Dil) | 4.87M | 4.25M | 3.22M | 2.62M | 5.47M |
Vicarious Surgical Reports Fourth Quarter and Full Year 2021 Financial Results
Vicarious Surgical Reports Fourth Quarter and Full Year 2021 Financial Results
Vicarious to Participate in Upcoming Investor Conferences
Vicarious Surgical to Report Fourth Quarter 2021 Financial Results on March 3, 2022
Vicarious Surgical to Report Fourth Quarter 2021 Financial Results on March 3, 2022
Vicarious Surgical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Vicarious Surgical to Participate in the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
Robotics Investments In December 2021
Vicarious Surgical Receives Three Built In Boston's 2022 Best Places to Work Awards
Vicarious Surgical Receives Three Built In Boston’s 2022 Best Places to Work Awards
Source: https://incomestatements.info
Category: Stock Reports